Top 10 Medical Stocks To Own For 2019


Computer Programs & Systems (NASDAQ: CPSI) and Perion Network Ltd Common Stock (NASDAQ:PERI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Analyst Recommendations

Get Computer Programs & Systems alerts:

This is a summary of current ratings for Computer Programs & Systems and Perion Network Ltd Common Stock, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Computer Programs & Systems 1 4 1 0 2.00
Perion Network Ltd Common Stock 0 0 0 0 N/A

Computer Programs & Systems presently has a consensus target price of $29.25, suggesting a potential downside of 12.43%. Given Computer Programs & Systems’ higher probable upside, equities research analysts plainly believe Computer Programs & Systems is more favorable than Perion Network Ltd Common Stock.

Top 10 Medical Stocks To Own For 2019: Eros International PLC(EROS)


Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Eros International (EROS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Harsh Chauhan]

    And the company finally seems to be getting its act together in India; it was earlier criticized for offering a very shallow content library at premium prices when compared to rivals. But cracking the Indian market will be easier said than done for Netflix, as one of India’s biggest production houses — Eros International (NYSE:EROS) — has now decided to join the video-streaming party.

  • [By Motley Fool Staff]

    Eros International (NYSE:EROS) Q4 2018 Earnings Conference CallJun. 27, 2018 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Garrett Baldwin]

    The secret to becoming a millionaire, of course, is getting out in front of a major investment trend before it becomes mainstream. In 2017, it was Bitcoin and cryptocurrencies. But this year, it’s a taboo investment that is creating millionaires all across North America. Tap into the “green rush,” and prepare to become a “Marijuana millionaire.” Learn how to get started right here.


    The Top Stock Market Stories for Wednesday
    U.S. President Donald Trump is facing criticism after threatening to ramp up taxes on Harley-Davidson Inc. (NYSE: HOG). The iconic motorcycle producer said it will move parts of its production overseas in order to avoid tariffs from the European Union. Trump threatened to increase taxes on the firm. “Surprised that Harley-Davidson, of all companies, would be the first to wave the White Flag,” Trump tweeted Tuesday. “I fought hard for them and ultimately they will not pay tariffs selling into the E.U., which has hurt us badly on trade, down $151 Billion. Taxes just a Harley excuse – be patient!” Earlier this month, Microsoft Corp. (Nasdaq: MSFT) launched a $7.5 billion takeover of the web-based hosting service GitHub. The acquisition, orchestrated by Microsoft CEO Satya Nadella, brought out critics who claim that GitHub lacks any real profit potential for Microsoft stock. Here’s why those critics are wrong… and why MSFT is a buy. Facebook Inc. (Nasdaq: FB) has reversed its policy on cryptocurrency ads. The social media giant says that it will permit marketing from “pre-approved advisers.” According to TechCrunch, the company will still ban ads pushing binary options and initial coin offerings. The report goes on to explain that cryptocurrency scams cost customers more than $500 million in just January and February 2018 alone.
    Four Stocks to Watch Today: ORCL, FB, GOOGL, BA
    Oracle Corp. (NYSE: ORCL) were largely flat despite a strong earnings report after the bell yesterday. The cloud computing giant reported EPS of $0.99

Top 10 Medical Stocks To Own For 2019: Wolverine World Wide, Inc.(WWW)


Advisors’ Opinion:

  • [By Joseph Griffin]

    Wolverine World Wide, Inc. (NYSE:WWW) – Stock analysts at DA Davidson dropped their Q3 2018 EPS estimates for Wolverine World Wide in a research note issued on Wednesday, August 8th. DA Davidson analyst M. Kawamoto now forecasts that the textile maker will post earnings of $0.54 per share for the quarter, down from their prior estimate of $0.56. DA Davidson currently has a “Buy” rating and a $44.00 price objective on the stock. DA Davidson also issued estimates for Wolverine World Wide’s Q4 2018 earnings at $0.54 EPS, FY2018 earnings at $2.13 EPS and FY2019 earnings at $2.33 EPS.

  • [By Ethan Ryder]

    Wolverine World Wide (NYSE:WWW)’s share price gapped up prior to trading on Thursday following a better than expected earnings announcement. The stock had previously closed at $33.18, but opened at $32.32. Wolverine World Wide shares last traded at $31.45, with a volume of 29527 shares changing hands.

  • [By Max Byerly]

    WealthTrust Fairport LLC acquired a new stake in Wolverine World Wide, Inc. (NYSE:WWW) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 18,654 shares of the textile maker’s stock, valued at approximately $649,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Wolverine World Wide (WWW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2019: United Technologies Corporation(UTX)

Advisors’ Opinion:

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage gain ahead of the close Thursday was United Technologies Corp. (NYSE: UTX) which traded up 3.33% at $133.56. The stock’s 52-week range is $107.05 to $139.24. Volume was about 50% above the daily average of around 4.3 million shares. The company’s CEO said that company is considering breaking itself into three pieces.

  • [By Max Byerly]

    United Technologies Co. (NYSE:UTX) has been given a consensus recommendation of “Buy” by the twenty research firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $142.00.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded up 2.75% at $129.47. The stock’s 52-week range is $107.05 to $139.24. Volume was about 20% below the daily average of around 4.2 million shares. When UTC completes its deal to acquire Rockwell Collins, a new Air Force bomber is part of the deal. The Defense Department budget for this year includes $2 billion for the program and the 2019 budget includes $2.3 billion.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded up 1.68% at $129.49. The stock’s 52-week range is $109.10 to $139.24. Volume was also about equal to the daily average of around 3.9 million shares.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded down 2.61% at $135.94. The stock’s 52-week range is $115.40 to $144.15. Volume was about equal to the daily average of around 3.6 million.

  • [By Adam Levine-Weinberg]

    In 2011, JetBlue Airways (NASDAQ:JBLU) ordered 86 aircraft engines from United Technologies (NYSE:UTX) unit Pratt & Whitney to power the 40 Airbus (NASDAQOTH:EADSY) A320neo-family airplanes it had ordered.

Top 10 Medical Stocks To Own For 2019: TTM Technologies, Inc.(TTMI)


Advisors’ Opinion:

  • [By Stephan Byrd]

    TTM Technologies, Inc. (NASDAQ:TTMI) has been assigned an average recommendation of “Buy” from the eight research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $20.40.

  • [By Shane Hupp]

    TTM Technologies (NASDAQ:TTMI) has been assigned a consensus recommendation of “Buy” from the eight analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $19.80.

  • [By Ethan Ryder]

    TTM Technologies (NASDAQ:TTMI) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Monday.

  • [By Taylor Cox]

    Investor Events

    Analyst/investor days for: PayPal Holdings, Inc (NASDAQ: PYPL), Cabot Corporation (NYSE: CBT), S&P Global Inc (NYSE: SPGI), Total System Services, Inc (NYSE: TSS), and TTM Technologies, Inc (NASDAQ: TTMI)
    Roku, Inc (NASDAQ: ROKU) annual shareholder meeting
    Equifax Inc (NYSE: EFX) will meet with investors in L.A.

    Friday

Top 10 Medical Stocks To Own For 2019: Century Casinos, Inc.(CNTY)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Century Casinos (NASDAQ:CNTY) from a hold rating to a buy rating in a report issued on Thursday.

    Several other research firms have also recently issued reports on CNTY. Zacks Investment Research raised shares of Century Casinos from a sell rating to a hold rating in a research note on Tuesday, January 30th. TheStreet cut shares of Century Casinos from a b rating to a c+ rating in a research note on Friday, April 6th. Finally, BidaskClub cut shares of Century Casinos from a hold rating to a sell rating in a research report on Tuesday, February 6th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $11.00.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Century Casinos (CNTY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    News stories about Century Casinos (NASDAQ:CNTY) have been trending somewhat positive this week, according to Accern. Accern scores the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Century Casinos earned a news impact score of 0.04 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 47.2296807992345 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Shane Hupp]

    News headlines about Century Casinos (NASDAQ:CNTY) have been trending somewhat positive on Wednesday, according to Accern Sentiment. Accern rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Century Casinos earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.6738306029486 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Medical Stocks To Own For 2019: L-3 Communications Holdings, Inc.(LLL)


Advisors’ Opinion:

  • [By Joseph Griffin]

    Colony Group LLC lifted its holdings in shares of L3 Technologies Inc (NYSE:LLL) by 1.6% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 22,697 shares of the aerospace company’s stock after purchasing an additional 363 shares during the quarter. Colony Group LLC’s holdings in L3 Technologies were worth $4,365,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on L3 Technologies (LLL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lou Whiteman]

    Things weren’t so rosy over at merger partner L3 Technologies (NYSE:LLL), which reported adjusted fourth-quarter earnings per share of $3.10, which was $0.40 ahead of estimates thanks to a lower tax rate, decreased share count, and other items. The company actually came in about $23 million light on operating earnings if you back out tax rates and other items for issues related to its business building traveling wave tube amplifiers.

  • [By ]

    The primary companies identified fitting the bill are Hubbell (NYSE: HUBB), Roper Technologies (NYSE: ROP), and L3 (NYSE: LLL).

    2. Short Semiconductors
    Domestic companies with high exposure to the Chinese market are in danger due to the proposed tariffs. High technology is on the top of the sector list with Chinese exposure. Digging deeper into the high tech sector, semiconductor companies have the highest Chinese exposure.

Top 10 Medical Stocks To Own For 2019: TeleNav Inc.(TNAV)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Telenav Inc (NASDAQ:TNAV) has received a consensus rating of “Buy” from the six analysts that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $11.17.

  • [By Stephan Byrd]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:


    Get Telenav alerts:

    Telenav, Inc. (TNAV) CEO HP Jin on Q4 2018 Results – Earnings Call Transcript (seekingalpha.com) Telenav EPS in-line, beats on revenue (seekingalpha.com) Telenav: Fiscal 4Q Earnings Snapshot (finance.yahoo.com) Telenav (TNAV) Reports Q4 Loss, Tops Revenue Estimates (finance.yahoo.com) Telenav (TNAV) Posts Earnings Results, Meets Estimates (americanbankingnews.com)

    TNAV has been the topic of a number of analyst reports. ValuEngine raised shares of Telenav from a “strong sell” rating to a “sell” rating in a research report on Saturday, June 2nd. B. Riley reaffirmed a “buy” rating on shares of Telenav in a research report on Monday, July 23rd. Finally, BidaskClub raised shares of Telenav from a “sell” rating to a “hold” rating in a research report on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $9.25.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Telenav (TNAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Telenav (NASDAQ:TNAV) from a sell rating to a hold rating in a research note published on Saturday.

    Several other equities research analysts also recently issued reports on TNAV. BidaskClub upgraded Telenav from a sell rating to a hold rating in a report on Friday. Zacks Investment Research upgraded Telenav from a sell rating to a hold rating in a report on Thursday, April 5th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $11.17.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Telenav (TNAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2019: Net 1 UEPS Technologies, Inc.(UEPS)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Net1 UEPS Technologies (NASDAQ:UEPS) jumped 15.7% on Friday after the alternative-payment systems specialist announced stronger-than-expected fiscal third-quarter 2018 results and an encouraging development regarding its social grants payments contract in South Africa.

  • [By Lisa Levin] Gainers
    Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors.
    Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading.
    Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday.
    Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday.
    Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday.
    Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading.
    TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday.
    CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading.
    Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading.
    International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday.
    Finisar
  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.


    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Logan Wallace]

    Net 1 UEPS Technologies (NASDAQ: UEPS) and Payment Data Systems (NASDAQ:PYDS) are both small-cap industrial products companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, analyst recommendations and valuation.

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.


    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Medical Stocks To Own For 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine downgraded shares of Interactive Brokers Group (NASDAQ:IBKR) from a buy rating to a hold rating in a report published on Tuesday.

    A number of other research firms also recently issued reports on IBKR. BidaskClub downgraded shares of Interactive Brokers Group from a buy rating to a hold rating in a research note on Friday, June 8th. Compass Point began coverage on shares of Interactive Brokers Group in a research note on Tuesday, June 5th. They set a neutral rating and a $74.00 price target on the stock. Zacks Investment Research downgraded shares of Interactive Brokers Group from a buy rating to a hold rating in a research note on Tuesday, June 19th. Finally, SunTrust Banks decreased their price target on shares of Interactive Brokers Group to $71.00 and set a $65.34 rating on the stock in a research note on Wednesday, July 18th. Four equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. Interactive Brokers Group presently has an average rating of Hold and an average price target of $69.86.

  • [By Logan Wallace]

    Interactive Brokers Group (NASDAQ:IBKR) had its price target cut by SunTrust Banks to $71.00 in a research report sent to investors on Wednesday. They currently have a $65.34 rating on the financial services provider’s stock. SunTrust Banks also issued estimates for Interactive Brokers Group’s Q3 2018 earnings at $0.54 EPS, Q4 2018 earnings at $0.59 EPS, FY2018 earnings at $2.34 EPS, Q1 2019 earnings at $0.60 EPS, Q2 2019 earnings at $0.64 EPS, Q3 2019 earnings at $0.66 EPS, Q4 2019 earnings at $0.70 EPS and FY2019 earnings at $2.60 EPS.

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

  • [By Max Byerly]

    Gamble Jones Investment Counsel increased its stake in shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 1.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,263 shares of the financial services provider’s stock after purchasing an additional 918 shares during the period. Gamble Jones Investment Counsel’s holdings in Interactive Brokers Group were worth $4,139,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Own For 2019: County Bancorp, Inc.(ICBK)


Advisors’ Opinion:

  • [By Stephan Byrd]

    County Bancorp Inc (NASDAQ:ICBK) President Timothy J. Schneider sold 1,000 shares of the stock in a transaction on Monday, June 4th. The shares were sold at an average price of $27.55, for a total value of $27,550.00. Following the completion of the sale, the president now owns 113,882 shares in the company, valued at $3,137,449.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

  • [By Max Byerly]

    Middlefield Banc (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings.

  • [By Max Byerly]

    Southern National Banc. of Virginia (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.

  • [By Shane Hupp]

    Guaranty Bancorp (NASDAQ:GBNK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on County Bancorp (ICBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published.